drugset / Trial / NCT00282360
Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Patients with coronary artery disease have an abnormal cardiac metabolism. The hypothesis of this study is that shifting cardiac metabolism from free fatty acids to glucose will improve myocardial ischemia
Timeline
- Start
- 1999-02
- Primary completion
- —
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trimetazidine | Small molecule | — | — |